Atomwise AI

Atomwise AI leverages its proprietary AtomNet® platform to accelerate small-molecule drug discovery with deep convolutional neural networks, enabling efficient virtual screening and optimization of a library of over 16 billion compounds.

Rating:

Visit Website

AI drug discoveryAtomNet platformvirtual screening of compoundssmall-molecule drug designdeep learning in drug discoverytarget binding prediction

Features of Atomwise AI

Based on the AtomNet® deep convolutional neural network, it accurately predicts interactions between small molecules and protein targets.

Capable of efficiently screening a virtual library containing more than 16 billion compounds, shortening the early discovery timeline from years to weeks.

Able to tackle hard-to-drug targets with limited structural data, expanding the frontier of drug discovery.

Validated through the AIMS program to achieve about 74% screening accuracy, with continued discovery of structurally novel compounds.

Supports the full early-stage drug discovery workflow from virtual screening to lead optimization and drug repurposing.

Use Cases of Atomwise AI

Pharmaceutical companies use it during the early drug discovery stage to rapidly screen large chemical libraries for promising lead compounds.

Research institutions use it to design new drug molecules for targets that lack crystal structures or are difficult for traditional methods to handle.

Biotech companies seek AI solutions to reduce R&D costs and accelerate programs, as an alternative to traditional experimental high-throughput screening.

Academic laboratories use the AIMS program to conduct large-scale, low-cost virtual screening validation studies for specific disease targets.

When responding to emerging public health events (e.g., Ebola), there is a need to identify potential therapeutic candidate molecules in an extremely short timeframe.

FAQ about Atomwise AI

QWhat is Atomwise AI?

Atomwise AI is an AI-powered biopharma company focused on accelerating small-molecule drug discovery and design using artificial intelligence, especially deep convolutional neural networks, with its core being the proprietary AtomNet® platform.

QWhat can the AtomNet platform mainly do?

The AtomNet platform can simulate molecular structures and predict the binding affinity between small molecules and protein targets, enabling efficient and accurate screening of virtual libraries containing hundreds of billions of compounds to identify promising drug candidate molecules.

QWhat are the advantages of using Atomwise AI for drug discovery?

The main advantages are dramatically improved screening efficiency and breadth, shortening the traditional multi-year early discovery timeline to weeks, exploring a broader chemical space, addressing difficult-to-drug targets, and reducing R&D costs.

QIn which disease areas is Atomwise AI technology applied?

Its technology has been applied across oncology, neurological disorders, rare diseases, immune and inflammatory diseases, among others, and it collaborates with multiple pharmaceutical companies and academic institutions on related target research.

QHow accurate is Atomwise AI's virtual screening?

According to validation data from its AIMS program, the AtomNet platform can screen targets with about 74% accuracy and continually discovers structurally novel compounds, serving as a viable alternative to traditional experimental screening.

QHow to collaborate with Atomwise AI?

Atomwise AI has established broad collaborations with major pharmaceutical and biotech companies and leading research universities worldwide; academic institutions can apply for targeted virtual screening studies through the AIMS program.

Similar Tools

Undermind AI

Undermind AI is an AI-powered platform for discovering and analyzing scientific literature, capable of reducing weeks of literature research to minutes and delivering efficient, precise AI-powered research support for researchers.

Tempus AI

Tempus AI is a precision medicine company that uses artificial intelligence and data platforms to integrate multimodal medical data, delivering data-driven solutions for clinical decision support, medical research and drug development.

Cradle AI

Cradle AI is a scientific platform that applies generative artificial intelligence to protein engineering and drug discovery, letting biologists design and optimize antibodies, enzymes and other biologics while cutting experimental cycles and boosting success rates.

Tamarind Bio AI

Tamarind Bio AI is a computational biology SaaS cloud platform that integrates AI with physical computing methods to help scientists efficiently tackle complex research tasks such as protein design, antibody engineering, and drug discovery.

Ontosight AI

Ontosight AI is an AI-powered research intelligence platform built for life-science and biomedical teams. It fuses massive scientific datasets with semantic search to speed up literature discovery, drug discovery and knowledge translation—while adding shared workspaces and writing assistance for faster publication.

1910 AI Biotechnology

1910 AI Biotechnology is an AI-native biotech company that accelerates the discovery and optimization of small-molecule and large-molecule drugs by integrating artificial intelligence with automated laboratory technologies.

Autoblocks AI

Autoblocks AI is an integrated platform for AI product development teams, designed to help engineers, product managers, and domain experts efficiently build, test, deploy, and manage AI applications based on large language models. The platform offers simulation testing, evaluation optimization, and collaboration tools, enabling data-driven, engineering-led development and iteration in high-stakes domains such as healthcare and finance.

Verge Genomics

Verge Genomics is a biotechnology company that uses an AI-powered platform to integrate large-scale human genomics data, focused on accelerating drug discovery for neurodegenerative diseases. Its technology aims to identify novel targets and predict candidate compounds, exploring possibilities to shorten the drug development timeline.

Oatmeal Health AI

Oatmeal Health AI is a medical services provider focused on early cancer screening. By applying AI-driven data analysis, it identifies high-risk patients and delivers a full-spectrum screening coordination service—from risk assessment to follow-up—aimed at improving accessibility to care and advancing health equity.

Prismer AI

Prismer AI is an AI-powered platform designed for scholars and professional researchers. By integrating workflows that streamline the research process, it helps users efficiently manage literature, perform deep analyses, and generate actionable insights.